Table 3.

Gene differentially expressed in the blood of TNBC patients versus that of ER/PR+ patients

Gene	Name	Fold regulation	95% CI	Adj P-value
IL10RB	Interleukin 10 receptor, beta	1.83	(0.24, 3.42)	0.012
IFNA2	Interferon, alpha 2	1.58	(1.15, 2.01)	0.038
CXCL13	Chemokine (C-X-C motif) ligand 13	1.52	(1.24, 1.79)	0.002
IL17C	Interleukin 17C	−3.91	(−12.5, −2.32)	0.000
IL17F	Interleukin 17F	−3.38	(−12.5, −1.96)	0.004
IL13	Interleukin 13	−2.92	(−12.5, −1.64)	0.038
CCL26	Chemokine (C-C motif) ligand 26	−2.55	(−12.5, −1.4)	0.023
CSF2	Colony-stimulating factor 2 (granulocyte-macrophage)	−2.49	(0.21, 0.59)	0.008
IL3	Interleukin 3 (colony-stimulating factor, multiple)	−2.49	(−4.76, −1.7)	0.011
OSM	Oncostatin M	−2.42	(−7.14, −1.45)	0.021
IL1A	Interleukin 1, alpha	−1.96	(−3.57, −1.35)	0.036
IL16	Interleukin 16	−1.68	(−3.84, −1.07)	0.008
IL5RA	Interleukin 5 receptor, alpha	−1.62	(−2.85, −1.13)	0.041
TNFSF13	Tumor necrosis factor (ligand) superfamily, member 13	−1.54	(−2.32, −1.14)	0.025

Abbreviations: TNBC, triple-negative breast cancer; ER, estrogen; PR, progesterone; CI, confidence interval; Adj, adjusted.